Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fitzgerald
E Michael

Showing results (861-870 of 2,771) with videos related to

Pageof 278
Sort By:
Current Opinion in Rheumatology|May 9, 2009
Denosumab updateE Michael Lewiecki
Cleveland Clinic Journal of Medicine|August 5, 2009
Managing osteoporosis: challenges and strategiesE Michael Lewiecki
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 29, 2010
Risk communication and shared decision making in the care of patients with osteoporosisE Michael Lewiecki
Discovery Medicine|October 28, 2011
Sclerostin: a novel target for intervention in the treatment of osteoporosisE Michael Lewiecki
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Denosumab in postmenopausal osteoporosis: what the clinician needs to knowE Michael Lewiecki
Endocrinology and Metabolism Clinics of North America|October 24, 2024
Utility of Trabecular Bone Score in the Management of Patients with OsteoporosisE Michael Lewiecki
Developmental Psychology|September 9, 2010
The value of reanalysis and replication: introduction to special sectionE Michael Foster
Expert Opinion on Biological Therapy|December 1, 2010
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosisE Michael Lewiecki
Current Medical Research and Opinion|November 6, 2010
Clinical use of denosumab for the treatment for postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Biological Therapy|September 23, 2006
RANK ligand inhibition with denosumab for the management of osteoporosisE Michael Lewiecki
Pageof 278

Showing results (861-870 of 2,771) with videos related to

Sort By:
Pageof 278
Current Opinion in Rheumatology|May 9, 2009
Denosumab updateE Michael Lewiecki
Cleveland Clinic Journal of Medicine|August 5, 2009
Managing osteoporosis: challenges and strategiesE Michael Lewiecki
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 29, 2010
Risk communication and shared decision making in the care of patients with osteoporosisE Michael Lewiecki
Discovery Medicine|October 28, 2011
Sclerostin: a novel target for intervention in the treatment of osteoporosisE Michael Lewiecki
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Denosumab in postmenopausal osteoporosis: what the clinician needs to knowE Michael Lewiecki
Endocrinology and Metabolism Clinics of North America|October 24, 2024
Utility of Trabecular Bone Score in the Management of Patients with OsteoporosisE Michael Lewiecki
Developmental Psychology|September 9, 2010
The value of reanalysis and replication: introduction to special sectionE Michael Foster
Expert Opinion on Biological Therapy|December 1, 2010
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosisE Michael Lewiecki
Current Medical Research and Opinion|November 6, 2010
Clinical use of denosumab for the treatment for postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Biological Therapy|September 23, 2006
RANK ligand inhibition with denosumab for the management of osteoporosisE Michael Lewiecki
Pageof 278